Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Assets: 2018-2020

Historic Assets for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2020 value amounting to $329.7 million.

  • Black Diamond Therapeutics' Assets fell 20.87% to $274.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $274.1 million, marking a year-over-year decrease of 20.87%. This contributed to the annual value of $329.7 million for FY2020, which is 108.26% up from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Assets of $329.7 million as of FY2020, which was up 108.26% from $158.3 million recorded in FY2019.
  • In the past 5 years, Black Diamond Therapeutics' Assets registered a high of $329.7 million during FY2020, and its lowest value of $51.8 million during FY2018.
  • Its 3-year average for Assets is $179.9 million, with a median of $158.3 million in 2019.
  • Data for Black Diamond Therapeutics' Assets shows a peak YoY skyrocketed of 205.44% (in 2019) over the last 5 years.
  • Over the past 3 years, Black Diamond Therapeutics' Assets (Yearly) stood at $51.8 million in 2018, then spiked by 205.44% to $158.3 million in 2019, then surged by 108.26% to $329.7 million in 2020.